The Mechanisms of Ferroptosis in the Pathogenesis of Kidney Diseases

Overview

Journal J Nephrol

Publisher Springer

Specialty Nephrology

Date 2024 May 4

PMID 38704472

Authors

Jia Liu

Jianheng Chen

Jie Lv

Yuhang Gong

Jie Song

Affiliations

Soon will be listed here.

Abstract

The pathological features of acute and chronic kidney diseases are closely associated with cell death in glomeruli and tubules. Ferroptosis is a form of programmed cell death characterized by iron overload-induced oxidative stress. Ferroptosis has recently gained increasing attention as a pathogenic mechanism of kidney damage. Specifically, the ferroptosis signaling pathway has been found to be involved in the pathological process of acute and chronic kidney injury, potentially contributing to the development of both acute and chronic kidney diseases. This paper aims to elucidate the underlying mechanisms of ferroptosis and its role in the pathogenesis of kidney disease, highlighting its significance and proposing novel directions for its treatment.

References

Kurzhagen J, Dellepiane S, Cantaluppi V, Rabb H . AKI: an increasingly recognized risk factor for CKD development and progression. J Nephrol. 2020; 33(6):1171-1187. DOI: 10.1007/s40620-020-00793-2. View

Belavgeni A, Meyer C, Stumpf J, Hugo C, Linkermann A . Ferroptosis and Necroptosis in the Kidney. Cell Chem Biol. 2020; 27(4):448-462. DOI: 10.1016/j.chembiol.2020.03.016. View

Stockwell B, Jiang X, Gu W . Emerging Mechanisms and Disease Relevance of Ferroptosis. Trends Cell Biol. 2020; 30(6):478-490. PMC: 7230071. DOI: 10.1016/j.tcb.2020.02.009. View

Maurer B, Metelitsa L, Seeger R, Cabot M, Reynolds C . Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst. 1999; 91(13):1138-46. DOI: 10.1093/jnci/91.13.1138. View

Dolma S, Lessnick S, Hahn W, Stockwell B . Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003; 3(3):285-96. DOI: 10.1016/s1535-6108(03)00050-3. View

Seiler A, Schneider M, Forster H, Roth S, Wirth E, Culmsee C . Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008; 8(3):237-48. DOI: 10.1016/j.cmet.2008.07.005. View

Yang W, Stockwell B . Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008; 15(3):234-45. PMC: 2683762. DOI: 10.1016/j.chembiol.2008.02.010. View

Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. PMC: 3367386. DOI: 10.1016/j.cell.2012.03.042. View

Skouta R, Dixon S, Wang J, Dunn D, Orman M, Shimada K . Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014; 136(12):4551-6. PMC: 3985476. DOI: 10.1021/ja411006a. View

10.

Gao M, Monian P, Quadri N, Ramasamy R, Jiang X . Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell. 2015; 59(2):298-308. PMC: 4506736. DOI: 10.1016/j.molcel.2015.06.011. View

11.

Kagan V, Mao G, Qu F, Friedmann Angeli J, Doll S, St Croix C . Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2016; 13(1):81-90. PMC: 5506843. DOI: 10.1038/nchembio.2238. View

12.

Cao J, Dixon S . Mechanisms of ferroptosis. Cell Mol Life Sci. 2016; 73(11-12):2195-209. PMC: 4887533. DOI: 10.1007/s00018-016-2194-1. View

13.

Li Y, Xiu W, Yang K, Wen Q, Yuwen L, Luo Z . A multifunctional Fenton nanoagent for microenvironment-selective anti-biofilm and anti-inflammatory therapy. Mater Horiz. 2021; 8(4):1264-1271. DOI: 10.1039/d0mh01921f. View

14.

Zhu W, Fang T, Zhang W, Liang A, Zhang H, Zhang Z . A ROS scavenging protein nanocage for and antioxidant treatment. Nanoscale. 2021; 13(8):4634-4643. DOI: 10.1039/d0nr08878a. View

15.

Yadav P, Sharma P, Sundaram S, Venkatraman G, Bera A, Karunagaran D . SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells. Cancer Lett. 2021; 522:211-224. DOI: 10.1016/j.canlet.2021.09.033. View

16.

Homma T, Kobayashi S, Fujii J . Cysteine preservation confers resistance to glutathione-depleted cells against ferroptosis via CDGSH iron sulphur domain-containing proteins (CISDs). Free Radic Res. 2020; 54(6):397-407. DOI: 10.1080/10715762.2020.1780229. View

17.

Su Y, Zhao B, Zhou L, Zhang Z, Shen Y, Lv H . Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 2020; 483:127-136. DOI: 10.1016/j.canlet.2020.02.015. View

18.

Chen X, Li J, Kang R, Klionsky D, Tang D . Ferroptosis: machinery and regulation. Autophagy. 2020; 17(9):2054-2081. PMC: 8496712. DOI: 10.1080/15548627.2020.1810918. View

19.

Lane D, Metselaar B, Greenough M, Bush A, Ayton S . Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease. Essays Biochem. 2021; 65(7):925-940. DOI: 10.1042/EBC20210017. View

20.

Wang Y, Zhang M, Bi R, Su Y, Quan F, Lin Y . ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol. 2022; 51:102262. PMC: 8857079. DOI: 10.1016/j.redox.2022.102262. View